Landmark Study Shows Antibody Therapy Controls 92% of Severe Asthma Cases
MSN,
Safer relief for people suffering from severe asthma is a step closer with a large clinical trial finding a monocolonal…
Landmark Study Shows Antibody Therapy Controls 92% of Severe Asthma Cases
Science Alert,
Safer relief for people suffering from severe asthma is a step closer with a large clinical trial finding a monocolonal…
A fuzzy based dietary clinical decision support system for patients with multiple chronic conditions (MCCs)
Health Reporter,
Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ – Nature
Alert Breaking News - US,
Inda, M.
The nutritional profile, mineral content and heavy metal uptake of yellow mealworm reared with supplementation of agricultural sidestreams
Health Reporter,
Estimating medication adherence from Electronic Health Records: comparing methods for mining and processing asthma treatment prescriptions | BMC Medical Research Methodology
Health Reporter,
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease – Nature
Alert Breaking News - US,
Parmar, M., Grealish, S.
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
BioTech Gate,
By: PR Newswire Association LLC. - 27 Jul 2021 AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that…
News story from Finanz Nachrichten on Tuesday 27 July 2021
Finanz Nachrichten,
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Finanzen,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Yahoo!,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
ProfitQuotes.com,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Ticker Tech,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
News story from PR Newswire UK on Tuesday 27 July 2021
PR Newswire UK,
News story from Finanz Nachrichten on Tuesday 27 July 2021
Finanz Nachrichten,
Grünenthal's Glucocorticoid Receptor Modulator Enters Clinical Development
The Street,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Benzinga,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Finanzen.ch,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
WFMZ-TV 69,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
PR Newswire,
AACHEN, Germany, July 27, 2021 /PRNewswire/ -- Grünenthal announced today that the first volunteers have been enrolled in a…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
Yahoo! Finance USA,
AACHEN, Germany, July 27, 2021 /PRNewswire/ Grünenthal announced today that the first volunteers have been enrolled in a Phase…
Grünenthal’s Glucocorticoid Receptor Modulator enters clinical development
TT,
CEST | Grünenthal Group Share Aachen, Germany, 27 July 2021 –Grünenthal announced today that the first volunteers have been…
Grünenthal’s Glucocorticoid Receptor Modulator enters clinical development
DMN Newswire!,
Aachen, Germany, 27 July 2021 – Grünenthal announced today that the first volunteers have been enrolled in a Phase I trial of…
Grünenthal beginnt mit der klinischen Entwicklung eines Glukokortikoid Rezeptor Modulators
Börse Express,
Quelle: OTS Wirtschaft Aachen (ots) - Grünenthal gab heute bekannt, dass die ersten Teilnehmer in eine Phase-I-Studie mit einem…
OTS: Grünenthal Group / Grünenthal beginnt mit der klinischen Entwicklung ...
Finanzen,
Grünenthal beginnt mit der klinischen Entwicklung eines Glukokortikoid Rezeptor Modulators Aachen (ots) - Grünenthal gab heute…
Grünenthal’s Glucocorticoid Receptor Modulator enters clinical development
KULR 8,
Grünenthal announced today that the first volunteers have been enrolled in a Phase I trial of its Glucocorticoid Receptor…
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
PRLeap,
Aachen, Germany - Grünenthal announced today that the first volunteers have been enrolled in a Phase I trial of its…